Category

United States

Daily Brief United States: IAC/InterActiveCorp, Brown Forman Corp Class B, Cintas Corp, Eastman Chemical Co, Hologic Inc and more

By | Daily Briefs, United States

In today’s briefing:

  • IAC Inc.: 4 Ways In Which This Company Is Shaping Its Long-Term Growth Prospects! – Key Drivers
  • Brown-Forman Corporation: How Resilience
  • Cintas Corporation: 4 Reasons Why Cintas is Leading the Way in Uniform Rental and Safety Services! – Financial Forecasts
  • Eastman Chemical Company: Unlocking Its Growth Potential With A Unique Strategic Approach! – Key Drivers
  • Hologic Inc.: 3 Key Drivers & Strategic Priorities Driving Growth – Financial Forecasts


IAC Inc.: 4 Ways In Which This Company Is Shaping Its Long-Term Growth Prospects! – Key Drivers

By Baptista Research

  • IAC managed to exceed analyst expectations in terms of revenue as well as earnings.
  • The company’s emphasis on core fundamentals and operational efficiency has yielded profitability and improved customer experiences.
  • IAC is also focused on driving revenue growth through investments in customer experience and strategic revenue reallocation.

Brown-Forman Corporation: How Resilience

By Baptista Research

  • Brown-Forman managed to surpass the revenue expectations and the earnings expectations of Wall Street.
  • With an increase in reported net sales, driven by organic growth and favorable price/mix, Brown-Forman demonstrated its ability to navigate challenges and capitalize on consumer demand.
  • Brands like Jack Daniel’s Tennessee Whiskey and Woodford Reserve were standout performers, showing organic net sales growth and capturing consumer attention through innovative campaigns and partnerships.

Cintas Corporation: 4 Reasons Why Cintas is Leading the Way in Uniform Rental and Safety Services! – Financial Forecasts

By Baptista Research

  • Cintas managed to exceed analyst expectations in terms of revenue as well as earnings.
  • The Uniform Rental and Facility Services segment experienced solid organic growth driven by increased volume and new customer acquisitions.
  • The company’s First Aid and Safety Services segment revenue grew 16.4% organically, driven by strong demand for first aid products and services, as well as training and compliance solutions whereas its All Other segment revenue grew 14.7% organically, driven by growth in fire protection services and direct sale uniform businesses.

Eastman Chemical Company: Unlocking Its Growth Potential With A Unique Strategic Approach! – Key Drivers

By Baptista Research

  • Eastman delivered a mixed result in the recent quarter, with revenues below market expectations, but it managed to surpass the analyst consensus in terms of earnings.
  • The company made improvements in the Fiber business due to increased prices and operational performance.
  • Supply-side factors, such as capacity reduction and effective capacity loss, have created tight markets and a focus on the security of supply.

Hologic Inc.: 3 Key Drivers & Strategic Priorities Driving Growth – Financial Forecasts

By Baptista Research

  • Hologic managed to exceed the revenue expectations as well as the earnings expectations of Wall Street.
  • The company’s financial results surpassed expectations, driven by robust organic revenue growth in key divisions like Diagnostics, Surgical, and Breast Health excluding COVID-19, driven by new products, market expansion and customer loyalty.
  • Hologic’s COVID-19 assay revenue was $233 million, down 47% sequentially, reflecting lower testing demand and increased competition.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: S&P 500 INDEX, Black Sesame Technologies and more

By | Daily Briefs, United States

In today’s briefing:

  • EQD | Introducing the Market Reversal Matrix (MRM): Predict Trend Reversal with Bayesian Models
  • Black Sesame Pre-IPO Tearsheet
  • China Designer of AI-Based Self-Driving Chips Files for Hong Kong IPO


EQD | Introducing the Market Reversal Matrix (MRM): Predict Trend Reversal with Bayesian Models

By Nico Rosti

  • A market-timing device that classifies historical trend patterns/reversals in “buckets”, to generate a “matrix” showing the market’s average trend reversal “behavior” at the end of each trend “type”. 
  • A purely statistical approach: using Bayesian Models to determine the probability of DAILY or WEEKLY trend reversal at precise LONG/SHORT support prices at fixed points in time.
  • The analogy with the game of Blackjack: knowing the probability of a trend reversal can be 30% or 90% (not always =50%) can be a significant edge for the investor.

Black Sesame Pre-IPO Tearsheet

By Sumeet Singh

  • Black Sesame International Holdings (BSIH) is looking to raise around US$300m in its upcoming Hong Kong IPO. The deal will be run by CICC and Huatai.
  • BSIH is an automotive-grade computing SoC and SoC-based intelligent vehicle solution provider. 
  • In terms of shipment of automotive-grade high-computing power SoCs in 2022, it was the third largest provider globally, according to Frost & Sullivan.

China Designer of AI-Based Self-Driving Chips Files for Hong Kong IPO

By Caixin Global

  • Black Sesame International Holding Ltd., a Xiaomi-backed designer of artificial intelligence-based self-driving computing chips, has filed for a Hong Kong IPO
  • Black Sesame, which also counts Tencent Holdings Ltd. and SAIC Motor Corp. Ltd. among its major investors, plans to use the IPO proceeds mainly to develop system-on-a-chip (SoC) designs and software for intelligent vehicles in the next three years.
  • Bloomberg in January reported that the company expects to raise $200 million through the share sale, citing people familiar with the matter.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Gracell Biotechnologies Inc, General Mills and more

By | Daily Briefs, United States

In today’s briefing:

  • Gracell Biotechnologies Inc (GRCL.US) – May Fail to Solve the Real Pain Points in CAR-T Field
  • General Mills: A Disappointing Quarter For Short-Term Investors And Speculators


Gracell Biotechnologies Inc (GRCL.US) – May Fail to Solve the Real Pain Points in CAR-T Field

By Xinyao (Criss) Wang

  • The latest data of GC012F/GC007g at ASCO/EHA drove up share price, but the current clinical data do not necessarily guarantee the final druggability. So, we advise investors to be rational.
  • Gracell’s pipeline may not solve the real pain points of CAR-T therapy. Until the global momentum of cell therapy is reversed, there’s no need to expect too much from Gracell.
  • Gracell’s stock price would continue to fluctuate with positive clinical data or progress. However, the liquidity of this stock isn’t good. In this situation, both ups and downs are meaningless. 

General Mills: A Disappointing Quarter For Short-Term Investors And Speculators

By Vladimir Dimitrov, CFA

  • General Mills has just reported its full fiscal year results and investors are not impressed.
  • Expectations of lower organic revenue growth and uncertainties around profitability would likely continue to weigh on the share price.
  • Long-term investors, however, could take advantage of this near-term dynamic while enjoying the higher dividend.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Talos Energy Inc, Cardano, Culp Inc, Earthstone Energy and more

By | Daily Briefs, United States

In today’s briefing:

  • Talos Energy, Inc. – Value Creation Catalysts
  • Q2 Liquidity Ranking for Crypto Assets
  • Culp, Inc. – 4QFY23: Results Beat Estimates; Trends Improve in Mattress Fabrics
  • Earthstone Energy, Inc – Delaware Expansion Adds Quality Inventory


Talos Energy, Inc. – Value Creation Catalysts

By Water Tower Research

  • Talos’s current valuation implies a steep discount to net asset value (NAV).

  • Management estimates the company’s year- end 2022 pro forma proved reserves have a gross PV-10 value of ~$5.5 billion (~$4.8 billion net of asset retirement obligations [ARO]) based on oil and natural gas prices of $75/bbl and $3.50/Mcf.

  • Adjusting for March 31, 2023, balance sheet items, leaves an estimated NAV of ~$3.6 billion, or $28.38/share.


Q2 Liquidity Ranking for Crypto Assets

By Kaiko

  • Towards the end of last year, I published the first liquidity ranking system for crypto assets, comparing each asset’s liquidity ranking to its market cap and investigating which token’s market cap is the most misleading from a liquidity standpoint.
  • In Q1 of this year I provided an update to the ranking system as overall market liquidity hit 10 month lows. 
  • The good news is that global liquidity has been more or less flat over Q2, with no further drops apart from  the tokens featured in the SEC lawsuits and a handful of exchange-specific drops in liquidity, such as Binance.US.

Culp, Inc. – 4QFY23: Results Beat Estimates; Trends Improve in Mattress Fabrics

By Water Tower Research

  • Beat expectations. After market close on June 28, Culp reported 4QFY23 results that exceeded expectations.

  • Total revenues were $61.4 million, beating our $54 million estimate and consensus of $55.5 million.

  • On the bottom line, the company’s EPS of ($0.38) beat our ($0.50) estimate and consensus of ($0.45).


Earthstone Energy, Inc – Delaware Expansion Adds Quality Inventory

By Water Tower Research

  • Earthstone announced an agreement to acquire Novo Oil & Gas Holdings LLC for $1.5 billion on June 15, 2023.

  • Concurrently, Northern Oil & Gas will acquire a pro rata one-third of the assets for $500 million from Earthstone, resulting in a net purchase price of $1.0 billion.

  • The transaction is expected to close in 3Q23 and will have an effective date of May 1, 2023.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Micron Technology, S&P 500 INDEX, Tesla Motors, Coeptis Therapeutics Holdings and more

By | Daily Briefs, United States

In today’s briefing:

  • Micron. Clutching At AI Straws
  • Meeting SPX and NDX Buy Levels
  • Tesla’s Panicky Q2: Everything Must Go!
  • Coeptis Therapeutics Inc. (COEP) YE22 1Q23 & DeSPAC 29062023


Micron. Clutching At AI Straws

By William Keating

  • Micron reported FQ3’23 revenues of $3.8 billion, up 2% sequentially and down 57% year-over-year.
  • Despite upbeat AI notes among others, Micron quietly delivered more bad news than good with their overall outlook worsening in many key respects. 
  • In the company’s own words, “Profitability and cash flow will remain extremely challenged for some time”. For “some time”, you could insert “at least 12 months”

Meeting SPX and NDX Buy Levels

By Thomas Schroeder

  • Cycle: Near term pullback a buy for a push into late June/early July (cycle has shifted right). Equities remain well supported. Increased volatility expected in July.
  • Met the SPX 4,370 buy level with firmer support at 4,350. Rally bias for a minor new high in the coming week+.
  • Measuring rally momentum for signs of a bigger stall cycle in July.

Tesla’s Panicky Q2: Everything Must Go!

By Vicki Bryan

  • Prices have been slashed and slashed again, on top of expensive incentives like free charging, cheap leases, & juicy subsidies. 
  • But Tesla has been unable to ease elevated inventory in key markets.
  • This signals even record deliveries will produce lower quality revenue and disappointing margins & profits for the second quarter.

Coeptis Therapeutics Inc. (COEP) YE22 1Q23 & DeSPAC 29062023

By ACF Equity Research

  • C&CE 1Q23A $2.1m, burn 1Q $1.6m, S-1MEF filed for raise
  • YE22A Opex $34.2m vs. $14.1 y/y, Δ is redemptions/merger costs
  • Warrants booked as liabilities (SEC de-SPAC ruling Apr 12, 2021)

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: MariMed, Oracle Corp and more

By | Daily Briefs, United States

In today’s briefing:

  • MariMed, Inc. – Management Series Report Cannabis
  • Oracle As A Long-Term Dividend Play


MariMed, Inc. – Management Series Report Cannabis

By Water Tower Research

  • MariMed is a multi-state operator (MSO) in the US cannabis industry.
  • It has a national footprint spanning six states: Illinois, Massachusetts, Maryland, Delaware, Ohio, and Missouri.
  • MariMed focuses on limited-license markets and strives to be vertically integrated wherever possible. 

Oracle As A Long-Term Dividend Play

By Vladimir Dimitrov, CFA

  • Oracle’s upside in the near term might appear limited, but there is potential for higher dividend growth going forward.
  • The debt level should be monitored closely by investors, but in my view does not present a major risk for Oracle’s dividend.
  • The dividend yield remains low, but the debt level must be monitored by investors.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Meta Platforms (Facebook), Ford Motor Co, Oddity Tech , iShares Russell 2000 ETF and more

By | Daily Briefs, United States

In today’s briefing:

  • Meta’s Achilles Heel(s)
  • Ford: Surprisingly Still Undervalued
  • Oddity Tech IPO Preview: AI In The Beauty Industry
  • Russell 2000 (IWM) Testing $180 Support; Breadth Remains Constructive; Construction/Engineering Buys


Meta’s Achilles Heel(s)

By MBI Deep Dives

  • First some caveats: while we have all probably read Charlie Munger’s quote “I never allow myself to hold an opinion on anything that I don’t know the other side’s argument better than they do”, the reality is this is exceptionally uncommon and challenging.
  • In fact, when investors mention risks about a company they like, they often deliberately choose strawman arguments from the other side and advertently or inadvertently ignore steelman arguments.
  • I will try to avoid strawman bear cases (and boy there are many), and only outline the bear cases that indeed concern me as a shareholder.

Ford: Surprisingly Still Undervalued

By Pearl Gray Equity and Research

  • Receding credit risk and a more predictable inflationary environment will likely deliver tailwinds to cyclical stocks.
  • The U.S. Government is set to throw its support behind the EV industry, and Ford might be a primary beneficiary.
  • However, we are giving the stock the benefit of the doubt.

Oddity Tech IPO Preview: AI In The Beauty Industry

By Andrei Zakharov

  • Oddity Tech (ODD US) , innovative consumer-tech unicorn and a prominent player in the beauty industry, filed for a $100M U.S. IPO, with Goldman Sachs leading the offering.
  • Founded in 2013 in Israel by CEO Mr. Holtzman and Chief Product Officer Ms. Holtzman-Erel, Oddity Tech (ODD US)  wants to disrupt the global beauty and wellness market.
  • Founder-Led company delivered profitable high-growth at a scale and has a rapidly growing user base. Given the company’s attractive fundamentals, Oddity Tech is bound to have a very successful IPO.

Russell 2000 (IWM) Testing $180 Support; Breadth Remains Constructive; Construction/Engineering Buys

By Joe Jasper

  • We discussed last week how consolidation was likely, so far that has played out with the SPX back testing the 4300-4325 area which we anticipated would cap upside for 2023.
  • We continue to watch short-term support at 4300, and we cannot be bearish if the S&P 500 is above 4300.
  • The Russell 2000 (IWM) is back to test support at $180; we would expect to see this hold as support, but a failure to hold would mean a trip to $170

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Earable, Bitcoin, Gold, Impinj Inc, Monster Beverage, Steelcase Inc Cl A and more

By | Daily Briefs, United States

In today’s briefing:

  • Samsung Ventures Invests in Sleeptech Firm Earable Neuroscience
  • What’s Driving Bitcoin’s Rally?
  • Soybeans Spike Due to Weather Worries – The Credit Crunch Isn’t over Yet
  • PI: Red Tagged, Initiating with Sell
  • Monster Beverage Corporation: Still A GARP Opportunity
  • Update Note – Steelcase, Inc. (SCS)


Samsung Ventures Invests in Sleeptech Firm Earable Neuroscience

By e27

  • Earable Neuroscience, a US-headquartered deep-tech company that has developed a sleep tech wearable device, has secured undisclosed bridge funding from Samsung Ventures.
  • Through this investment, Samsung Ventures plans to forge alliances within its local and global network to support Earable Neuroscience’s global expansion, including the Korean market.
  • Established in 2018 by Vietnamese founder Tam Vu, the startup’s sleep tech wearable, FRENZ Brainband, incorporates cutting-edge neuroscience technology into a consumer wearable to enhance sleep quality, improve focus, and promote relaxation.

What’s Driving Bitcoin’s Rally?

By Kaiko

  • Bitcoin briefly hit yearly highs over the weekend and is up 15% week-on-week.
  • What’s driving this rapid surge in prices?
  • While news of a Blackrock ETF filing is certainly a bullish catalyst, let’s see what the data says. 

Soybeans Spike Due to Weather Worries – The Credit Crunch Isn’t over Yet

By The Commodity Report

  • Soybeans spike due to weather worries The worst U.S. Midwest drought since 2012 expanded over the past week despite mild temperatures as a lack of rain across the heart of the American farm belt threatened newly seeded crops.
  • Below-average rainfall and high winds also exacerbated drought conditions in many regions.
  • In the early growing stage of the crops, drought can be compensated by more rain in the later stages.

PI: Red Tagged, Initiating with Sell

By Hamed Khorsand

  • Impinj was a late beneficiary to the COVID-19 pandemic and could now be on the cusp of a correction in its revenue growth trajectory
  • The developer of radio frequency identification (“RFID”) chips used in RFID tags benefited when companies were facing supply chain issues resulting in ordering much more inventory than necessary
  • Consensus estimates are for another 36 percent increase in revenue in 2023 even though Impinj is heavily dependent on retail apparel

Monster Beverage Corporation: Still A GARP Opportunity

By Pearl Gray Equity and Research

  • Qualitative factors and key metrics suggest that Monster Beverage Corporation presents a GARP opportunity.
  • The company is growing at scale and holds down a significant part of the energy drinks market.
  • The generational consumer shift into stimulated drinks lends researchers much scope to delve into the prospects of Monster Beverage Corporation (NASDAQ:MNST).

Update Note – Steelcase, Inc. (SCS)

By Water Tower Research

  • This note follows up on the Steelcase 1QFY24 earnings release, management’s earnings conference call, and our earnings analysis note from June 22.
  • Herein, we refresh our estimates for Steelcase.
  • Steelcase has been tied to the fortunes of commercial/contract furniture, where the company is a global leader. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Technology Select Sector SPDR, NFT and more

By | Daily Briefs, United States

In today’s briefing:

  • A Focus on AI and Technology Stocks
  • Rabby Wallet


A Focus on AI and Technology Stocks

By Cam Hui

  • The adoption of AI promises to be highly disruptive and has to potential to improve profitability of companies that adopt the technology.
  • It faces regulatory hurdles and risk-pricing challenges as insurance companies learn to price AI risk, but those problems are a few years away.
  • In the near term, the technology rally appears extended and may need a breather.

Rabby Wallet

By Etherbridge

  • This article delves into the intricacies of Rabby Wallet, an innovative browser extension wallet devised by DeBank.
  • The wallet is engineered to respond effectively to the needs of participants within the increasingly complex and rapidly expanding arena of Decentralised Finance (DeFi).
  • In the realm of blockchain technology, where DeFi continues to grow and evolve, wallets such as Rabby are of paramount importance. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief United States: Intel Corp and more

By | Daily Briefs, United States

In today’s briefing:

  • Intel Planing on Pulling A Samsung


Intel Planing on Pulling A Samsung

By William Keating

  • By combining TMG+TD+IFS into a single reportable segment, all internal demand will move to this new entity, leapfrogging Intel to global #2 foundry by Q1’24 instead of by 2030
  • This new structure risks obfuscating the details of external foundry customer growth
  • A much simpler step by step approach which achieves all Intel’s stated goals while retaining visibility into IFS would be far more preferable from a shareholder perspective

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars